Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A quick guide to the year-end tax forms required for ETFs and tips to ensure correct reporting on your return.
24,251 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
In a market thirsting for the next big tech winner, the steady power of dividend growth often goes unseen. This artic...
Non-QM mortgage products are expanding to serve gig workers and freelancers, signaling a major shift in access to hom...
AMLP delivered a record May 2026 payout and a 14% trailing return, underscoring resilient midstream cash flow. Invest...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
SVOL harvests the volatility risk premium by shorting VIX futures, paying a high dividend, yet a volatile market test...
Two popular bank-focused ETFs offer different paths to tap the U.S. financial sector. This piece breaks down broad ba...
Looking to build retirement wealth with a focus on AI? This guide highlights three AI stocks worth holding until reti...
As summer heat climbs, the strait hormuz still closed reshapes energy markets and portfolios. This guide translates r...
SoundHound AI aims to own the voice layer that connects users to services. This article builds a practical bull case ...
Venture firm Andreessen Horowitz and a growing mix of banks push a five-year horizon for autonomous AI agents to func...
A major fund manager disclosed a sizable exit from a tactical commodity ETF, signaling a shift in market stance. This...